The alliance will give providers the ability to review patients' social care history, monitor at-risk populations and track outcomes within MEDITECH's EHR.
The funds will be used to advance Insilico's drug pipeline and lab, which automates the research and development process, and refine its AI-enabled models and algorithms.
The funds will be used to expand the U.S. and European reach of its FDA-cleared tinnitus treatment device, Lenire, including with the Department of Veterans Affairs.